MYCOBACTERIUM TUBERCULOSIS AND DNA FINGERPRINTING: A VITAL TOOL FOR TRACKING OUTBREAKS
Main Article Content
Keywords
DNA Fingerprinting, Multi Drug Resistance, Genes, Strains
Abstract
Abstract: Genetic fingerprinting has been incorporated into epidemiological research to investigate TB micro-epidemics. TB control aims to pinpoint areas of transmission to halt the spread of the disease. accurate diagnosis of TB infection is essential to prevent disease progression. Traditional epidemiological studies, which relied on identifying plausible opportunities for transmission based on shared environments, have been greatly enhanced by the introduction of genetic techniques. The ability to characterize infecting organisms through DNA fingerprints has provided invaluable insights into the transmission dynamics of tuberculosis. By integrating these genetic data with traditional clinical, epidemiological, and public health information, we have gained a more comprehensive understanding of how tuberculosis spreads within populations. Moving forward, the continued use and refinement of tuberculosis DNA fingerprinting techniques will be crucial in identifying transmission links, guiding targeted interventions, and ultimately, reducing the burden of tuberculosis worldwide..This powerful tool holds the potential to revolutionize tuberculosis control strategies and bring us closer to achieving the goal of eliminating this disease as a global health threat
References
1. Long R, Njoo H, Hershfield E. Tuberculosis: 3. Epidemiology of the disease in Canada. CMAJ. 1999;160(8):1185-90. PMID 10234352.
2. Fitzgerald JM, Black WA, Kunimoto D. Evaluation of non-HIV-related drug-sensitive cluster outbreaks of tuberculosis with PCR-based DNA finger-printing. Can Respir J. 1996;3(5):317-21. doi: 10.1155/1996/723501.
3. Brancker A, Enarson DA, Grzybowski S, Hershfield ES, Jeanes CW. A statistical chronicle of tuberculosis in Canada: Part II. Risk today and control. Health Rep. 1992;4(3):277-92. PMID 1493198.
4. Selwyn PA, Hartel D, Lewis VA, Schoenbaum EE, Vermund SH, Klein RS, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med. 1989;320(9):545-50. doi: 10.1056/NEJM198903023200901, PMID 2915665.
5. Behr MA, Small PM. Molecular fingerprinting of Mycobacterium tuberculosis: how can it help the clinician. Clin Infect Dis. 1997;25(4):806-10. doi: 10.1086/515550, PMID 9356792.
6. Yang ZH, de Haas PEW, Wachmann CH, van Soolingen D, van Embden JDA, Andersen AB. Molecular epidemiology of tuberculosis in Denmark in 1992. J Clin Microbiol. 1995;33(8):2077-81. doi: 10.1128/jcm.33.8.2077-2081.1995, PMID 7559951.
7. Cave MD, Eisenach KD, McDermott JH, Bates JH, Crawford JT. IS6110 Conservation in the Mycobacterium tuberculosis complex and its utilisation in DNA fingerprinting. Mol Cell Probes. 1991;5:73-80.
8. De Boer AS, Borgdorff MW, de Haas PE, Nagelkerke NJ, van Embden JD, van Soolingen D. Analysis of rate of change of IS6110 RFLP patterns of Mycobacterium tuberculosis based on serial patient isolates. J Infect Dis. 1999;180(4):1238-44. doi: 10.1086/314979, PMID 10479153.
9. Van Embden JD, Cave MD, Crawford JT, Dale JW, Eisenach KD, Gicquel B, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol. 1993;31(2):406-9. doi: 10.1128/jcm.31.2.406-409.1993, PMID 8381814.
10. Daley CL, Small PM, Schecter GF, Schoolnik GK, McAdam RA, Jacobs WR Jr, et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. N Engl J Med. 1992;326(4):231-5. doi: 10.1056/NEJM199201233260404, PMID 1345800.
11. Edlin BR, Tokars JI, Grieco MH, Crawford JT, Williams J, Sordillo EM, et al. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med. 1992;326(23):1514-21. doi: 10.1056/NEJM199206043262302, PMID 1304721.
12. Kline SE, Hedemark LL, Davies SF. Outbreak of tuberculosis among regular patrons of a neighborhood bar. N Engl J Med. 1995;333(4):222-7. doi: 10.1056/NEJM199507273330404, PMID 7791838.
13. Small PM, McClenny NB, Singh SP, Schoolnik GK, Tompkins LS, Mickelsen PA. Molecular strain typing of Mycobacterium tuberculosis to confirm cross-contamination in the mycobacteriology laboratory and modification of procedures to minimize occurrence of false-positive cultures. J Clin Microbiol. 1993;31(7):1677-82. doi: 10.1128/jcm.31.7.1677-1682.1993, PMID 8102372.
14. Wurtz R, Demarais P, Trainor W, McAuley J, Kocka F, Mosher L, et al. Specimen contamination in mycobacteriology laboratory detected by pseudo-outbreak of multidrug-resistant tuberculosis: analysis by routine epidemiology and confirmation by molecular technique. J Clin Microbiol. 1996;34(4):1017-9. doi: 10.1128/jcm.34.4.1017-1019.1996, PMID 8815074.
15. Small PM, Shafer RW, Hopewell PC, Singh SP, Murphy MJ, Desmond E, et al. Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. N Engl J Med. 1993;328(16):1137-44. doi: 10.1056/NEJM199304223281601, PMID 8096066.
16. Shafer RW, Singh SP, Larkin C, Small PM. Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in an immunocompetent patient. Tuber Lung Dis. 1995;76(6):575-7. doi: 10.1016/0962-8479(95)90537-5, PMID 8593382.
17. Yeh RW, Hopewell PC, Daley CL. Simultaneous infection with two strains of Mycobacterium tuberculosis identified by restriction fragment length polymorphism analysis. Int J Tuberc Lung Dis. 1999;3(6):537-9. PMID 10383069.
18. Barnes PF, El-Hajj H, Preston-Martin S. Transmission of tuberculosis among urban homeless. JAMA. 1996;275:305-7.
19. Genewein A, Telenti A, Bernasconi C, Mordasini C, Weiss S, Maurer AM, et al. Molecular approach to identifying route of transmission of tuberculosis in the community. Lancet. 1993;342(8875):841-4. doi: 10.1016/0140-6736(93)92698-s, PMID 8104275.
20. Small PM, Hopewell PC, Singh SP, Paz A, Parsonnet J, Ruston DC, et al. The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N Engl J Med. 1994;330(24):1703-9. doi: 10.1056/NEJM199406163302402, PMID 7910661.
21. Alland D, Kalkut GE, Moss AR, McAdam RA, Hahn JA, Bosworth W, et al. Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med. 1994;330(24):1710-6. doi: 10.1056/NEJM199406163302403, PMID 7993412.
22. Chin DP, DeRiemer K, Small PM, de Leon AP, Steinhart R, Schecter GF, et al. Difference in contributing factors to tuberculosis incidence in U.S.-born and foreign-born persons. Am J Respir Crit Care Med. 1998;158(6):1797-803. doi: 10.1164/ajrccm.158.6.9804029, PMID 9847270.
23. Jasmer RM, Hahn JA, Small PM, Daley CL, Behr MA, Moss AR, et al. A molecular epidemiologic analysis of tuberculosis trends in San Francisco, 1991-1997. Ann Intern Med. 1999;130(12):971-8. doi: 10.7326/0003-4819-130-12-199906150-00004, PMID 10383367.
24. Behr MA, Warren SA, Salamon II, Hopewell PC, Ponce de Leon A, Daley CL, et al. Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli [published erratum appears in Lancet 1999;353:1714]. Lancet. 1999;353:444-9.
25. Valway SE, Sanchez MP, Shinnick TF, Orme I, Agerton T, Hoy D, et al. An outbreak involving extensive transmission of a virulent strain of Mycobacterium tuberculosis [published erratum appears in N Engl J Med 1998;338:1783]. N Engl J Med. 1998;338(10):633-9. doi: 10.1056/NEJM199803053381001, PMID 9486991.
26. Ten Asbroek AH, Borgdorff MW, Nagelkerke NJ, Sebek MM, Devillé W, van Embden JD, et al. Estimation of serial interval and incubation period of tuberculosis using DNA fingerprinting. Int J Tuberc Lung Dis. 1999;3(5):414-20. PMID 10331731.
27. Braden CR, Templeton GL, Cave MD, Valway S, Onorato IM, Castro KG, et al. Interpretation of restriction fragment length polymorphism analysis of Myobacterium tuberculosis isolates from a state with a large rural population. J Infect Dis. 1997;175(6):1446-52. doi: 10.1086/516478, PMID 9180185.
28. Agasino CB, Ponce de Leon A, Jasmer RM, Small PM. Epidemiology of Mycobacterium tuberculosis strains in San Francisco that do not contain IS6110. Int J Tuberc Lung Dis. 1998;2:521-3.
29. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, et al. Simultaneous detection and strain differentiation of Myobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol. 1997;35(4):907-14. doi: 10.1128/jcm.35.4.907-914.1997, PMID 9157152.
30. Petruccioli E, Scriba TJ, Petrone L, Hatherill M, Cirillo DM, Joosten SA, et al. Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis. Eur Respir J. 2016;48(6):1751-63. doi: 10.1183/13993003.01012-2016, PMID 27836953.
31. Goletti D, Petrone L, Ippolito G, Niccoli L, Nannini C, Cantini F. Preventive therapy for tuberculosis in rheumatological patients undergoing therapy with biological drugs. Expert Rev Anti-Infect Ther. 2018;16(6):501-12. doi: 10.1080/14787210.2018.1483238, PMID 29848120.
32. Santos JA, Duarte R, Nunes C. Tuberculin skin test and interferon-γ release assays: can they agree? Clin Respir J. 2023;17(2):109-14. doi: 10.1111/crj.13569, PMID 36526296.
33. Arend SM, Geluk A, van Meijgaarden KE, van Dissel JT, Theisen M, Andersen P, et al. Antigenic equivalence of human T-Cell responses to mycobacterium tuberculosis-specific RD1-Encoded Protein Antigens ESAT-6 and culture filtrate protein 10 and to mixtures of synthetic peptides. Infect Immun. 2000;68(6):3314-21. doi: 10.1128/IAI.68.6.3314-3321.2000, PMID 10816479.
34. Li F, Xu M, Qin C, Xia L, Xiong Y, Xi X, et al. Recombinant fusion ESAT6-CFP10 immunogen as a skin test reagent for tuberculosis diagnosis: an open-label, randomized, two-centre phase 2a clinical trial. Clin Microbiol Infect. 2016;22(10):.e889.9–:e889.16. doi: 10.1016/j.cmi.2016.07.015, PMID 27451942.
35. Ruhwald M, Aggerbeck H, Gallardo RV, Hoff ST, Villate JI, Borregaard B, et al. Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon γ release assay and the tuberculin skin test: a phase 3, double-blind, randomised, controlled trial. Lancet Respir Med. 2017;5(4):259-68. doi: 10.1016/S2213-2600(16)30436-2, PMID 28159608.
36. Nikitina IY, Karpina NL, Kasimceva OV, Gergert VY, Ergeshov A, Lyadova IV. Comparative performance of QuantiFERON-TB Gold versus skin test with tuberculosis recombinant allergen (Diaskintest) among patients with suspected pulmonary tuberculosis in Russia. Int J Infect Dis. 2019;86:18-24. doi: 10.1016/j.ijid.2019.06.014, PMID 31269455.
37. Krutikov M, Faust L, Nikolayevskyy V, Hamada Y, Gupta RK, Cirillo D, et al. The diagnostic performance of novel skin-based in-vivo tests for tuberculosis infection compared with purified protein derivative tuberculin skin tests and blood-based in vitro interferon-γ release assays: a systematic review and meta-analysis. Lancet Infect Dis. 2022;22(2):250-64. doi: 10.1016/S1473-3099(21)00261-9, PMID 34606768.
38. Shafeque A, Bigio J, Hogan CA, Pai M, Banaei N. Fourth-generation QuantiFERON-TB gold plus: what is the evidence? J Clin Microbiol. 2020;58(9):e01950–19. doi: 10.1128/JCM.01950-19, PMID 32493779.
39. American Thoracic Society. Diagnostic standards and classification of tuberculosis in adults and children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med. 2000;161(4 Pt 1):1376-95. doi: 10.1164/ajrccm.161.4.16141, PMID 10764337.
40. Frieden TR, Fujiwara PI, Washko RM, Hamburg MA. Tuberculosis in New York City; turning the tide. N Engl J Med. 1995;333(4):229-33. doi: 10.1056/NEJM199507273330406, PMID 7791840.
41. Crawford JT. Applications of molecular methods to epidemiology of tuberculosis. Res Microbiol. 1993;144(2):111-6. doi: 10.1016/0923-2508(93)90024-v, PMID 8101661.
42. Nardell E, McInnis B, Thomas B, Weidhaas S. Exogenous reinfection with tuberculosis in a shelter for the homeless. N Engl J Med. 1986;315(25):1570-5. doi: 10.1056/NEJM198612183152502, PMID 3097543.
43. Small PM, McClenny NB, Singh SP, Schoolnik GK, Tompkins LS, Mickelsen PA. Molecular strain typing of Mycobacterium tuberculosis to confirm cross-contamination in the mycobacteriology laboratory and modification of procedures to minimize occurrence of false-positive cultures. J Clin Microbiol. 1993;31(7):1677-82. doi: 10.1128/jcm.31.7.1677-1682.1993, PMID 8102372.
44. Nivin B, Driscoll J, Glaser T, Bifani P, Munsiff S. Use of spoligotype analysis to detect laboratory cross-contamination. Infect Control Hosp Epidemiol. 2000;21(8):525-7. doi: 10.1086/501799, PMID 10968719.
45. Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998;393(6685):537-44. doi: 10.1038/31159, PMID 9634230.
46. van Embden JD, Cave MD, Crawford JT, Dale JW, Eisenach KD, Gicquel B, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol. 1993;31(2):406-9. doi: 10.1128/jcm.31.2.406-409.1993, PMID 8381814.
47. Heersma HF, Kremer K, van Embden JD. Computer analysis of IS6110 RFLP patterns of Mycobacterium tuberculosis. In: Parish T, Stoker NG, editors. Methods in microbiology. Totowa, NJ: Humana Press; 1998. p. 395-422.
48. Driscoll JR, McGarry MA, Taber HW. DNA-typing of a nonviable culture of Mycobacterium tuberculosis in a homeless shelter outbreak. J Clin Microbiol. 1999;37(1):274-5. doi: 10.1128/JCM.37.1.274-275.1999, PMID 9988591.
49. Hermans PWM, van Soolingen D, Bik EM, de Haas PE, Dale JW, van Embden JD. Insertion element IS987 from Mycobacterium bovis BCG is located in a hot-spot integration region for insertion elements in Mycobacterium tuberculosis complex strains. Infect Immun. 1991;59(8):2695-705. doi: 10.1128/iai.59.8.2695-2705.1991, PMID 1649798.
50. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol. 1997;35(4):907-14. doi: 10.1128/jcm.35.4.907-914.1997, PMID 9157152.
51. Dale JW, Brittain D, Cataldi AA, Cousins D, Crawford JT, Driscoll J, et al. Spacer oligonucleotide typing of bacteria of the Mycobacterium tuberculosis complex: recommendations for standardized nomenclature. Int J Tuberc Lung Dis. 2001;5(3):216-9. PMID 11326819.
52. Kremer K, van Soolingen D, Frothingham R, Haas WH, Hermans PW, Martín C, et al. Comparison of methods based on different molecular epidemiological markers for typing of Mycobacterium tuberculosis complex strains: interlaboratory study of discriminatory power and reproducibility. J Clin Microbiol. 1999;37(8):2607-18. doi: 10.1128/JCM.37.8.2607-2618.1999, PMID 10405410.
53. Bifani P, Moghazeh S, Shopsin B, Driscoll J, Ravikovitch A, Kreiswirth BN. Molecular characterization of Mycobacterium tuberculosis H37Rv/Ra variants: distinguishing the mycobacterial laboratory strain. J Clin Microbiol. 2000;38(9):3200-4. doi: 10.1128/JCM.38.9.3200-3204.2000, PMID 10970357.
54. Institute of Medicine. Ending neglect: the elimination of tuberculosis in the United States. Committee on the Elimination of Tuberculosis in the United States. Washington, DC: National Academy Press; 2000.
55. Comstock GW. Tuberculosis in twins: A re-analysis of the Prophit survey. Am Rev Respir Dis. 1978;117(4):621-4. doi: 10.1164/arrd.1978.117.4.621, PMID 565607, Google Scholar.
56. Schurr E. Is susceptibility to tuberculosis acquired or inherited? J Intern Med. 2007;261(2):106-11. doi: 10.1111/j.1365-2796.2006.01741.x, PMID 17241175, Google Scholar.
57. Hirano K, Abe C, Takahashi M. Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis strains isolated mostly in Asian countries and their rapid detection by line probe assay. J Clin Microbiol. 1999;37(8):2663-6. (PMC Free article). doi: 10.1128/JCM.37.8.2663-2666.1999, PMID 10405418, Google Scholar.
58. Kapur V, Li LL, Iordanescu S, Hamrick MR, Wanger A, Kreiswirth BN et al. Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase beta subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas. J Clin Microbiol. 1994;32(4):1095-8. (PMC Free article). doi: 10.1128/jcm.32.4.1095-1098.1994, PMID 8027320, Google Scholar.
59. Mahmood N, Bhatti S, Abbas SN, Shahid S, Nasir SB. The pncA gene mutations of Mycobacterium tuberculosis in multidrug-resistant tuberculosis. Biotechnol Appl Biochem. 2022 Oct;69(5):2195-204. doi: 10.1002/bab.2278, PMID 34731907.
60. Amini S, et al. The 7H11 agar medium supplemented with calf bovine serum for susceptibility testing of Mycobacterium tuberculosis isolates against pyrazinamide Microb Drug Resist. 2021 Dec. PMID;61:34077245. Falzon D, Jaramillo E, Schunemann HJ, Arentz M, Bauer M, Bayona J, Blanc L, Caminero JA, Daley CL, Duncombe C, Fitzpatrick C, Gebhard A, Getahun H, Henkens M, Holtz TH, Keravec J, Keshavjee S, Khan AJ, Kulier R, Leimane V, Lienhardt C, Lu C, Mariandyshev A, Migliori GB, Mirzayev F, Mitnick CD, Nunn P, Nwagboniwe G, Oxlade O, Palmero D, Pavlinac P, Quelapio MI, Raviglione MC, Rich ML, Royce S, Rusch-Gerdes S, Salakaia A, Sarin R, Sculier D, Varaine F, Vitoria M, Walson JL, Wares F, Weyer K, White RA, Zignol M. 2011. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J 38:516–528. doi: 10.1183/09031936.00073611. [PubMed] [CrossRef] [Google Scholar].
61. Centers for Disease Control and Prevention. Notice to readers: revised definition of extensively drug-resistant tuberculosis. MMWR Morb Mortal Wkly Rep. 2006;55:1176. Google Scholar.
62. Lai CC, Tan CK, Huang YT, Chou CH, Hung CC, Yang PC et al. Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan. Clin Infect Dis. 2008;47(7):e57-63. doi: 10.1086/591702, PMID 18715157 [CrossRef]. Google Scholar.
63. Chernyaeva E, Fedorova E, Zhemkova G, Korneev Y, Kozlov A. Characterization of multiple and extensively drug resistant Mycobacterium tuberculosis isolates with different ofloxacin-resistance levels. Tuberc (Edinb). 2013;93(3):291-5. doi: 10.1016/j.tube.2013.02.005, PMID 23491718 [CrossRef]. Google Scholar.
64. Maruri F, Sterling TR, Kaiga AW, Blackman A, van der Heijden YF, Mayer C et al. A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system. J Antimicrob Chemother. 2012;67(4):819-31. doi: 10.1093/jac/dkr566. (PMC Free article). PMID 22279180 [CrossRef]. Google Scholar.
65. Devasia R, Blackman A, Eden S, Li H, Maruri F, Shintani A et al. High proportion of fluoroquinolone-resistant Mycobacterium tuberculosis isolates with novel gyrase polymorphisms and a gyrA region associated with fluoroquinolone susceptibility. J Clin Microbiol. 2012;50(4):1390-6. doi: 10.1128/JCM.05286-11. (PMC Free article). PMID 22189117 [CrossRef]. Google Scholar.
66. Murray PR, Baron EJ. Manual of clinical microbiology. 9th ed. Washington, DC: ASM Press; 2007. Google Scholar.
67. Clinical and Laboratory Standards Institute. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes; approved standard—2nd ed. CLSI document M24-A2. Wayne, PA: Clinical and Laboratory Standards Institute; 2011. Google Scholar.
68. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol. 1997;35(4):907-14. (PMC Free article). doi: 10.1128/jcm.35.4.907-914.1997, PMID 9157152, Google Scholar.
2. Fitzgerald JM, Black WA, Kunimoto D. Evaluation of non-HIV-related drug-sensitive cluster outbreaks of tuberculosis with PCR-based DNA finger-printing. Can Respir J. 1996;3(5):317-21. doi: 10.1155/1996/723501.
3. Brancker A, Enarson DA, Grzybowski S, Hershfield ES, Jeanes CW. A statistical chronicle of tuberculosis in Canada: Part II. Risk today and control. Health Rep. 1992;4(3):277-92. PMID 1493198.
4. Selwyn PA, Hartel D, Lewis VA, Schoenbaum EE, Vermund SH, Klein RS, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med. 1989;320(9):545-50. doi: 10.1056/NEJM198903023200901, PMID 2915665.
5. Behr MA, Small PM. Molecular fingerprinting of Mycobacterium tuberculosis: how can it help the clinician. Clin Infect Dis. 1997;25(4):806-10. doi: 10.1086/515550, PMID 9356792.
6. Yang ZH, de Haas PEW, Wachmann CH, van Soolingen D, van Embden JDA, Andersen AB. Molecular epidemiology of tuberculosis in Denmark in 1992. J Clin Microbiol. 1995;33(8):2077-81. doi: 10.1128/jcm.33.8.2077-2081.1995, PMID 7559951.
7. Cave MD, Eisenach KD, McDermott JH, Bates JH, Crawford JT. IS6110 Conservation in the Mycobacterium tuberculosis complex and its utilisation in DNA fingerprinting. Mol Cell Probes. 1991;5:73-80.
8. De Boer AS, Borgdorff MW, de Haas PE, Nagelkerke NJ, van Embden JD, van Soolingen D. Analysis of rate of change of IS6110 RFLP patterns of Mycobacterium tuberculosis based on serial patient isolates. J Infect Dis. 1999;180(4):1238-44. doi: 10.1086/314979, PMID 10479153.
9. Van Embden JD, Cave MD, Crawford JT, Dale JW, Eisenach KD, Gicquel B, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol. 1993;31(2):406-9. doi: 10.1128/jcm.31.2.406-409.1993, PMID 8381814.
10. Daley CL, Small PM, Schecter GF, Schoolnik GK, McAdam RA, Jacobs WR Jr, et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. N Engl J Med. 1992;326(4):231-5. doi: 10.1056/NEJM199201233260404, PMID 1345800.
11. Edlin BR, Tokars JI, Grieco MH, Crawford JT, Williams J, Sordillo EM, et al. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med. 1992;326(23):1514-21. doi: 10.1056/NEJM199206043262302, PMID 1304721.
12. Kline SE, Hedemark LL, Davies SF. Outbreak of tuberculosis among regular patrons of a neighborhood bar. N Engl J Med. 1995;333(4):222-7. doi: 10.1056/NEJM199507273330404, PMID 7791838.
13. Small PM, McClenny NB, Singh SP, Schoolnik GK, Tompkins LS, Mickelsen PA. Molecular strain typing of Mycobacterium tuberculosis to confirm cross-contamination in the mycobacteriology laboratory and modification of procedures to minimize occurrence of false-positive cultures. J Clin Microbiol. 1993;31(7):1677-82. doi: 10.1128/jcm.31.7.1677-1682.1993, PMID 8102372.
14. Wurtz R, Demarais P, Trainor W, McAuley J, Kocka F, Mosher L, et al. Specimen contamination in mycobacteriology laboratory detected by pseudo-outbreak of multidrug-resistant tuberculosis: analysis by routine epidemiology and confirmation by molecular technique. J Clin Microbiol. 1996;34(4):1017-9. doi: 10.1128/jcm.34.4.1017-1019.1996, PMID 8815074.
15. Small PM, Shafer RW, Hopewell PC, Singh SP, Murphy MJ, Desmond E, et al. Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. N Engl J Med. 1993;328(16):1137-44. doi: 10.1056/NEJM199304223281601, PMID 8096066.
16. Shafer RW, Singh SP, Larkin C, Small PM. Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in an immunocompetent patient. Tuber Lung Dis. 1995;76(6):575-7. doi: 10.1016/0962-8479(95)90537-5, PMID 8593382.
17. Yeh RW, Hopewell PC, Daley CL. Simultaneous infection with two strains of Mycobacterium tuberculosis identified by restriction fragment length polymorphism analysis. Int J Tuberc Lung Dis. 1999;3(6):537-9. PMID 10383069.
18. Barnes PF, El-Hajj H, Preston-Martin S. Transmission of tuberculosis among urban homeless. JAMA. 1996;275:305-7.
19. Genewein A, Telenti A, Bernasconi C, Mordasini C, Weiss S, Maurer AM, et al. Molecular approach to identifying route of transmission of tuberculosis in the community. Lancet. 1993;342(8875):841-4. doi: 10.1016/0140-6736(93)92698-s, PMID 8104275.
20. Small PM, Hopewell PC, Singh SP, Paz A, Parsonnet J, Ruston DC, et al. The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N Engl J Med. 1994;330(24):1703-9. doi: 10.1056/NEJM199406163302402, PMID 7910661.
21. Alland D, Kalkut GE, Moss AR, McAdam RA, Hahn JA, Bosworth W, et al. Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med. 1994;330(24):1710-6. doi: 10.1056/NEJM199406163302403, PMID 7993412.
22. Chin DP, DeRiemer K, Small PM, de Leon AP, Steinhart R, Schecter GF, et al. Difference in contributing factors to tuberculosis incidence in U.S.-born and foreign-born persons. Am J Respir Crit Care Med. 1998;158(6):1797-803. doi: 10.1164/ajrccm.158.6.9804029, PMID 9847270.
23. Jasmer RM, Hahn JA, Small PM, Daley CL, Behr MA, Moss AR, et al. A molecular epidemiologic analysis of tuberculosis trends in San Francisco, 1991-1997. Ann Intern Med. 1999;130(12):971-8. doi: 10.7326/0003-4819-130-12-199906150-00004, PMID 10383367.
24. Behr MA, Warren SA, Salamon II, Hopewell PC, Ponce de Leon A, Daley CL, et al. Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli [published erratum appears in Lancet 1999;353:1714]. Lancet. 1999;353:444-9.
25. Valway SE, Sanchez MP, Shinnick TF, Orme I, Agerton T, Hoy D, et al. An outbreak involving extensive transmission of a virulent strain of Mycobacterium tuberculosis [published erratum appears in N Engl J Med 1998;338:1783]. N Engl J Med. 1998;338(10):633-9. doi: 10.1056/NEJM199803053381001, PMID 9486991.
26. Ten Asbroek AH, Borgdorff MW, Nagelkerke NJ, Sebek MM, Devillé W, van Embden JD, et al. Estimation of serial interval and incubation period of tuberculosis using DNA fingerprinting. Int J Tuberc Lung Dis. 1999;3(5):414-20. PMID 10331731.
27. Braden CR, Templeton GL, Cave MD, Valway S, Onorato IM, Castro KG, et al. Interpretation of restriction fragment length polymorphism analysis of Myobacterium tuberculosis isolates from a state with a large rural population. J Infect Dis. 1997;175(6):1446-52. doi: 10.1086/516478, PMID 9180185.
28. Agasino CB, Ponce de Leon A, Jasmer RM, Small PM. Epidemiology of Mycobacterium tuberculosis strains in San Francisco that do not contain IS6110. Int J Tuberc Lung Dis. 1998;2:521-3.
29. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, et al. Simultaneous detection and strain differentiation of Myobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol. 1997;35(4):907-14. doi: 10.1128/jcm.35.4.907-914.1997, PMID 9157152.
30. Petruccioli E, Scriba TJ, Petrone L, Hatherill M, Cirillo DM, Joosten SA, et al. Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis. Eur Respir J. 2016;48(6):1751-63. doi: 10.1183/13993003.01012-2016, PMID 27836953.
31. Goletti D, Petrone L, Ippolito G, Niccoli L, Nannini C, Cantini F. Preventive therapy for tuberculosis in rheumatological patients undergoing therapy with biological drugs. Expert Rev Anti-Infect Ther. 2018;16(6):501-12. doi: 10.1080/14787210.2018.1483238, PMID 29848120.
32. Santos JA, Duarte R, Nunes C. Tuberculin skin test and interferon-γ release assays: can they agree? Clin Respir J. 2023;17(2):109-14. doi: 10.1111/crj.13569, PMID 36526296.
33. Arend SM, Geluk A, van Meijgaarden KE, van Dissel JT, Theisen M, Andersen P, et al. Antigenic equivalence of human T-Cell responses to mycobacterium tuberculosis-specific RD1-Encoded Protein Antigens ESAT-6 and culture filtrate protein 10 and to mixtures of synthetic peptides. Infect Immun. 2000;68(6):3314-21. doi: 10.1128/IAI.68.6.3314-3321.2000, PMID 10816479.
34. Li F, Xu M, Qin C, Xia L, Xiong Y, Xi X, et al. Recombinant fusion ESAT6-CFP10 immunogen as a skin test reagent for tuberculosis diagnosis: an open-label, randomized, two-centre phase 2a clinical trial. Clin Microbiol Infect. 2016;22(10):.e889.9–:e889.16. doi: 10.1016/j.cmi.2016.07.015, PMID 27451942.
35. Ruhwald M, Aggerbeck H, Gallardo RV, Hoff ST, Villate JI, Borregaard B, et al. Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon γ release assay and the tuberculin skin test: a phase 3, double-blind, randomised, controlled trial. Lancet Respir Med. 2017;5(4):259-68. doi: 10.1016/S2213-2600(16)30436-2, PMID 28159608.
36. Nikitina IY, Karpina NL, Kasimceva OV, Gergert VY, Ergeshov A, Lyadova IV. Comparative performance of QuantiFERON-TB Gold versus skin test with tuberculosis recombinant allergen (Diaskintest) among patients with suspected pulmonary tuberculosis in Russia. Int J Infect Dis. 2019;86:18-24. doi: 10.1016/j.ijid.2019.06.014, PMID 31269455.
37. Krutikov M, Faust L, Nikolayevskyy V, Hamada Y, Gupta RK, Cirillo D, et al. The diagnostic performance of novel skin-based in-vivo tests for tuberculosis infection compared with purified protein derivative tuberculin skin tests and blood-based in vitro interferon-γ release assays: a systematic review and meta-analysis. Lancet Infect Dis. 2022;22(2):250-64. doi: 10.1016/S1473-3099(21)00261-9, PMID 34606768.
38. Shafeque A, Bigio J, Hogan CA, Pai M, Banaei N. Fourth-generation QuantiFERON-TB gold plus: what is the evidence? J Clin Microbiol. 2020;58(9):e01950–19. doi: 10.1128/JCM.01950-19, PMID 32493779.
39. American Thoracic Society. Diagnostic standards and classification of tuberculosis in adults and children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med. 2000;161(4 Pt 1):1376-95. doi: 10.1164/ajrccm.161.4.16141, PMID 10764337.
40. Frieden TR, Fujiwara PI, Washko RM, Hamburg MA. Tuberculosis in New York City; turning the tide. N Engl J Med. 1995;333(4):229-33. doi: 10.1056/NEJM199507273330406, PMID 7791840.
41. Crawford JT. Applications of molecular methods to epidemiology of tuberculosis. Res Microbiol. 1993;144(2):111-6. doi: 10.1016/0923-2508(93)90024-v, PMID 8101661.
42. Nardell E, McInnis B, Thomas B, Weidhaas S. Exogenous reinfection with tuberculosis in a shelter for the homeless. N Engl J Med. 1986;315(25):1570-5. doi: 10.1056/NEJM198612183152502, PMID 3097543.
43. Small PM, McClenny NB, Singh SP, Schoolnik GK, Tompkins LS, Mickelsen PA. Molecular strain typing of Mycobacterium tuberculosis to confirm cross-contamination in the mycobacteriology laboratory and modification of procedures to minimize occurrence of false-positive cultures. J Clin Microbiol. 1993;31(7):1677-82. doi: 10.1128/jcm.31.7.1677-1682.1993, PMID 8102372.
44. Nivin B, Driscoll J, Glaser T, Bifani P, Munsiff S. Use of spoligotype analysis to detect laboratory cross-contamination. Infect Control Hosp Epidemiol. 2000;21(8):525-7. doi: 10.1086/501799, PMID 10968719.
45. Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998;393(6685):537-44. doi: 10.1038/31159, PMID 9634230.
46. van Embden JD, Cave MD, Crawford JT, Dale JW, Eisenach KD, Gicquel B, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol. 1993;31(2):406-9. doi: 10.1128/jcm.31.2.406-409.1993, PMID 8381814.
47. Heersma HF, Kremer K, van Embden JD. Computer analysis of IS6110 RFLP patterns of Mycobacterium tuberculosis. In: Parish T, Stoker NG, editors. Methods in microbiology. Totowa, NJ: Humana Press; 1998. p. 395-422.
48. Driscoll JR, McGarry MA, Taber HW. DNA-typing of a nonviable culture of Mycobacterium tuberculosis in a homeless shelter outbreak. J Clin Microbiol. 1999;37(1):274-5. doi: 10.1128/JCM.37.1.274-275.1999, PMID 9988591.
49. Hermans PWM, van Soolingen D, Bik EM, de Haas PE, Dale JW, van Embden JD. Insertion element IS987 from Mycobacterium bovis BCG is located in a hot-spot integration region for insertion elements in Mycobacterium tuberculosis complex strains. Infect Immun. 1991;59(8):2695-705. doi: 10.1128/iai.59.8.2695-2705.1991, PMID 1649798.
50. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol. 1997;35(4):907-14. doi: 10.1128/jcm.35.4.907-914.1997, PMID 9157152.
51. Dale JW, Brittain D, Cataldi AA, Cousins D, Crawford JT, Driscoll J, et al. Spacer oligonucleotide typing of bacteria of the Mycobacterium tuberculosis complex: recommendations for standardized nomenclature. Int J Tuberc Lung Dis. 2001;5(3):216-9. PMID 11326819.
52. Kremer K, van Soolingen D, Frothingham R, Haas WH, Hermans PW, Martín C, et al. Comparison of methods based on different molecular epidemiological markers for typing of Mycobacterium tuberculosis complex strains: interlaboratory study of discriminatory power and reproducibility. J Clin Microbiol. 1999;37(8):2607-18. doi: 10.1128/JCM.37.8.2607-2618.1999, PMID 10405410.
53. Bifani P, Moghazeh S, Shopsin B, Driscoll J, Ravikovitch A, Kreiswirth BN. Molecular characterization of Mycobacterium tuberculosis H37Rv/Ra variants: distinguishing the mycobacterial laboratory strain. J Clin Microbiol. 2000;38(9):3200-4. doi: 10.1128/JCM.38.9.3200-3204.2000, PMID 10970357.
54. Institute of Medicine. Ending neglect: the elimination of tuberculosis in the United States. Committee on the Elimination of Tuberculosis in the United States. Washington, DC: National Academy Press; 2000.
55. Comstock GW. Tuberculosis in twins: A re-analysis of the Prophit survey. Am Rev Respir Dis. 1978;117(4):621-4. doi: 10.1164/arrd.1978.117.4.621, PMID 565607, Google Scholar.
56. Schurr E. Is susceptibility to tuberculosis acquired or inherited? J Intern Med. 2007;261(2):106-11. doi: 10.1111/j.1365-2796.2006.01741.x, PMID 17241175, Google Scholar.
57. Hirano K, Abe C, Takahashi M. Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis strains isolated mostly in Asian countries and their rapid detection by line probe assay. J Clin Microbiol. 1999;37(8):2663-6. (PMC Free article). doi: 10.1128/JCM.37.8.2663-2666.1999, PMID 10405418, Google Scholar.
58. Kapur V, Li LL, Iordanescu S, Hamrick MR, Wanger A, Kreiswirth BN et al. Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase beta subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas. J Clin Microbiol. 1994;32(4):1095-8. (PMC Free article). doi: 10.1128/jcm.32.4.1095-1098.1994, PMID 8027320, Google Scholar.
59. Mahmood N, Bhatti S, Abbas SN, Shahid S, Nasir SB. The pncA gene mutations of Mycobacterium tuberculosis in multidrug-resistant tuberculosis. Biotechnol Appl Biochem. 2022 Oct;69(5):2195-204. doi: 10.1002/bab.2278, PMID 34731907.
60. Amini S, et al. The 7H11 agar medium supplemented with calf bovine serum for susceptibility testing of Mycobacterium tuberculosis isolates against pyrazinamide Microb Drug Resist. 2021 Dec. PMID;61:34077245. Falzon D, Jaramillo E, Schunemann HJ, Arentz M, Bauer M, Bayona J, Blanc L, Caminero JA, Daley CL, Duncombe C, Fitzpatrick C, Gebhard A, Getahun H, Henkens M, Holtz TH, Keravec J, Keshavjee S, Khan AJ, Kulier R, Leimane V, Lienhardt C, Lu C, Mariandyshev A, Migliori GB, Mirzayev F, Mitnick CD, Nunn P, Nwagboniwe G, Oxlade O, Palmero D, Pavlinac P, Quelapio MI, Raviglione MC, Rich ML, Royce S, Rusch-Gerdes S, Salakaia A, Sarin R, Sculier D, Varaine F, Vitoria M, Walson JL, Wares F, Weyer K, White RA, Zignol M. 2011. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J 38:516–528. doi: 10.1183/09031936.00073611. [PubMed] [CrossRef] [Google Scholar].
61. Centers for Disease Control and Prevention. Notice to readers: revised definition of extensively drug-resistant tuberculosis. MMWR Morb Mortal Wkly Rep. 2006;55:1176. Google Scholar.
62. Lai CC, Tan CK, Huang YT, Chou CH, Hung CC, Yang PC et al. Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan. Clin Infect Dis. 2008;47(7):e57-63. doi: 10.1086/591702, PMID 18715157 [CrossRef]. Google Scholar.
63. Chernyaeva E, Fedorova E, Zhemkova G, Korneev Y, Kozlov A. Characterization of multiple and extensively drug resistant Mycobacterium tuberculosis isolates with different ofloxacin-resistance levels. Tuberc (Edinb). 2013;93(3):291-5. doi: 10.1016/j.tube.2013.02.005, PMID 23491718 [CrossRef]. Google Scholar.
64. Maruri F, Sterling TR, Kaiga AW, Blackman A, van der Heijden YF, Mayer C et al. A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system. J Antimicrob Chemother. 2012;67(4):819-31. doi: 10.1093/jac/dkr566. (PMC Free article). PMID 22279180 [CrossRef]. Google Scholar.
65. Devasia R, Blackman A, Eden S, Li H, Maruri F, Shintani A et al. High proportion of fluoroquinolone-resistant Mycobacterium tuberculosis isolates with novel gyrase polymorphisms and a gyrA region associated with fluoroquinolone susceptibility. J Clin Microbiol. 2012;50(4):1390-6. doi: 10.1128/JCM.05286-11. (PMC Free article). PMID 22189117 [CrossRef]. Google Scholar.
66. Murray PR, Baron EJ. Manual of clinical microbiology. 9th ed. Washington, DC: ASM Press; 2007. Google Scholar.
67. Clinical and Laboratory Standards Institute. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes; approved standard—2nd ed. CLSI document M24-A2. Wayne, PA: Clinical and Laboratory Standards Institute; 2011. Google Scholar.
68. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol. 1997;35(4):907-14. (PMC Free article). doi: 10.1128/jcm.35.4.907-914.1997, PMID 9157152, Google Scholar.
Article Sidebar
Published
May 10, 2023
Article Details
How to Cite
Akanksha Verma, Shraddha Singh, Abhijeet Kashyap, Rakesh Saini, Ritik Dogra, Anirudh Sharma, Ankita Singh, Narotam Sharma, & Vijay Kumar. (2023). MYCOBACTERIUM TUBERCULOSIS AND DNA FINGERPRINTING: A VITAL TOOL FOR TRACKING OUTBREAKS. Journal of Population Therapeutics and Clinical Pharmacology, 30(11), 509-520. https://doi.org/10.53555/jptcp.v30i11.4539
Section
Articles
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Author Biographies
Akanksha Verma
DNA Labs- A Centre for Applied Sciences, Dehardun, UK
Shraddha Singh
DNA Labs- A Centre for Applied Sciences, Dehardun, UK
Abhijeet Kashyap
Uttaranchal University, Dehradun, UK
Rakesh Saini
Uttaranchal University, Dehradun, UK
Ritik Dogra
Himachal Pradesh University, Summer Hills, Shimla, HP
Anirudh Sharma
Himachal Pradesh University, Summer Hills, Shimla, HP
Ankita Singh
DNA Labs- A Centre for Applied Sciences, Dehardun, UK
Narotam Sharma
Himachal Pradesh University, Summer Hills, Shimla, HP
Vijay Kumar
DNA Labs- A Centre for Applied Sciences, Dehardun, UK
How to Cite
Akanksha Verma, Shraddha Singh, Abhijeet Kashyap, Rakesh Saini, Ritik Dogra, Anirudh Sharma, Ankita Singh, Narotam Sharma, & Vijay Kumar. (2023). MYCOBACTERIUM TUBERCULOSIS AND DNA FINGERPRINTING: A VITAL TOOL FOR TRACKING OUTBREAKS. Journal of Population Therapeutics and Clinical Pharmacology, 30(11), 509-520. https://doi.org/10.53555/jptcp.v30i11.4539